Answers are grounded in this paper and cite their sources.
Background: Amblyopia is a neurodevelopmental disorder of vision and a leading cause of monocular visual impairment in childhood. Standard management, refractive correction followed by occlusion (patching) or pharmacological penalization, is effective but constrained by poor adherence, psychosocial burden, residual deficits, recurrence after cessation, and diminishing response with age. Methods: A narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, Web of Science and the Cochrane Library, prioritizing randomized controlled trials, systematic reviews and key mechanistic studies. Results: Five families of emerging approaches were identified: (1) binocular and dichoptic therapy, (2) perceptual learning and action video games, (3) pharmacological adjuncts (levodopa, citicoline and plasticity-modulating agents), (4) non-invasive brain stimulation, and (5) paradigms that reactivate cortical plasticity, such as dark exposure and brief monocular deprivation. A dichoptic digital therapeutic has shown benefit over spectacles alone in a controlled trial, but large pragmatic trials of binocular games have not shown superiority to part-time patching, and the largest levodopa trial found no added benefit. Evidence for stimulation and plasticity-reactivation approaches remains preliminary and is drawn mainly from small studies and animal models. Conclusion: Optical correction and occlusion or penalization remains first-line care. Binocular digital therapy is a reasonable alternative or adjunct when adherence is a concern, while other strategies require larger, sham-controlled trials with standardized outcomes and long-term follow-up.
No takes yet. Share an insight, caveat, or question.
1*Hebah Mohammad Abbaas Al-Shraiedeh (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: